•  
  •  
 

Abstract

Nuclear medicine clinic needs have drastically changed with the emergence of theranostics, exciting new agents in the fight against cancer. However, administering these agents is a resource-intensive task, increasing demand for physician consultation time with patients, clinic office space, and scanner time. We examined our institution’s nuclear medicine clinic workflow and interviewed the clinic’s front desk staff, technologists, nurses, managers, physicians, and patients to find sources of delays, dissatisfaction, and decreased efficiency. An Ishikawa diagram and decision matrix helped us determine the most impactful intervention with our available resources. For this cycle, we focused on the consent process. Theranostic patients are usually on a standard therapy regimen with 4 or 6 doses of the same radiopharmaceutical. In our clinic, patients and physicians had to sign a separate consent form for each cycle, a repetitive task that was not standard across institutions or required by our hospital policy. We created a new consent form that included the full treatment regimen. In addition, we developed new patient education handouts to provide a reference that patients can keep when they leave the clinic. This intervention did not significantly decrease patients’ average clinic dwell time, but it allowed physicians and technologists to focus on patient care rather than repetitive paperwork, resulting in a 20% decrease in the physician-patient consultation time and eliminating an extra task. We were able to use lean methodology to eliminate a source of redundancy identified by patients, technologists, and physicians and improve provider satisfaction. Theranostics are a growing and integral part of nuclear medicine, and this project provides a framework for optimization of patient care and clinic efficiency.

DOI

https://doi.org/10.52519/ACEQI.25.1.2.a9

Creative Commons License

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.

Consent Form.pdf (108 kB)
Consent Form

Patient Handout-Lutathera-(Lutetium-Lu-177-Dotatate).pdf (154 kB)
Patient Handout - Lutathera

Patient Handout-PLUVICTO-(Lutetium-Lu-177-Vipivotide-Tetraxetan).pdf (154 kB)
Patient Handout - Pluvicto

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.